• The global life science tools market is expected to grow from $179.44 billion in 2024 to $455.30 billion by 2033, driven by technological advancements in genomics, proteomics, and AI-powered analytics.
• North America currently leads the market with a 39% share, while the Asia Pacific region is anticipated to experience the fastest growth rate due to increasing investments and expanding healthcare infrastructure.
• Key growth drivers include rising demand for personalized medicine, increasing prevalence of chronic diseases, and substantial investments in R&D by pharmaceutical companies and government initiatives.